Chuanming Xie - Publications

Ganoderic acid T, a novel activator of pyruvate carboxylase, exhibits potent anti-liver cancer activity.

Journal: Metabolism: clinical and experimental

Published: December 29, 2024

Integrative multiomic analysis identifies distinct molecular subtypes of NAFLD in a Chinese population.

Journal: Science translational medicine

Published: November 06, 2024

F-box protein FBXO32 ubiquitinates and stabilizes D-type cyclins to drive cancer progression.

Journal: Nature communications

Published: May 05, 2024

CircPTPRA promotes the progression of pancreatic ductal adenocarcinoma via the miR-140-5p/LMNB1 axis.

Journal: Cancer medicine

Published: November 16, 2022

Silencing of FAM111B inhibited proliferation, migration and invasion of hepatoma cells through activating p53 pathway.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: November 15, 2022

An optimized protocol to detect protein ubiquitination and activation by ubiquitination assay in vivo and CCK-8 assay.

Journal: STAR protocols

Published: October 04, 2022

Cancer type classification using plasma cell-free RNAs derived from human and microbes.

Journal: eLife

Published: November 01, 2021

p53 haploinsufficiency and increased mTOR signalling define a subset of aggressive hepatocellular carcinoma.

Journal: Journal of hepatology

Published: May 03, 2020

Effects of Y Box Binding Protein-1 in Progression and Prognosis of Cholangiocarcinoma.

Journal: Journal of investigative surgery : the official journal of the Academy of Surgical Research

Published: September 07, 2019

Activation of PTEN by inhibition of TRPV4 suppresses colon cancer development.

Journal: Cell death & disease

Published: January 17, 2019

miR-23a-5p inhibits cell proliferation and invasion in pancreatic ductal adenocarcinoma by suppressing ECM1 expression.

Journal: American journal of translational research

Published: December 18, 2018